CMF-01615 | MCM6 | down-regulates | SIX6 | represses | R-3175 | 4 | 2 | Drugs (1) |
CMF-01862 | DAO | down-regulates | ELF4 | activates | R-3010 | 20 | 3 | Drugs (9) |
CMF-01972 | PCDH9 | down-regulates | ELF4 | activates | R-3010 | 20 | 5 | Drugs (9) |
CMF-04898 | ABCC5 | up-regulates | FOXD3 | represses | R-572 | 25 | 7 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-05011 | NUP210L | up-regulates | FOXD3 | represses | R-572 | 25 | 4 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-05033 | NUP210L | down-regulates | ELF4 | activates | R-3010 | 20 | 4 | Drugs (9) |
CMF-05904 | BCL6 | down-regulates | FOXD3 | represses | R-572 | 25 | 2 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-06320 | MATN4 | up-regulates | FOXD3 | represses | R-572 | 25 | 3 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-07025 | ATRX | down-regulates | ELF4 | activates | R-3010 | 20 | 11 | Drugs (9) |
CMF-08076 | TRIM6-TRIM34 | down-regulates | ELF4 | activates | R-3010 | 20 | 3 | Drugs (9) |
CMF-09274 | RP1 | down-regulates | ELF4 | activates | R-3010 | 20 | 8 | Drugs (9) |
CMF-10812 | KIAA1012 | down-regulates | FOXD3 | represses | R-572 | 25 | 1 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-12327 | GPR98 | down-regulates | ELF4 | activates | R-3010 | 20 | 10 | Drugs (9) |
CMF-13259 | SULF2 | up-regulates | FOXD3 | represses | R-572 | 25 | 4 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-13277 | SULF2 | down-regulates | ELF4 | activates | R-3010 | 20 | 6 | Drugs (9) |
CMF-14116 | HEATR7B2 | down-regulates | ELF4 | activates | R-3010 | 20 | 3 | Drugs (9) |
CMF-14621 | C1orf177 | down-regulates | SIX6 | represses | R-3175 | 4 | 1 | Drugs (1) |
CMF-15393 | DSE | down-regulates | SIX6 | represses | R-3175 | 4 | 2 | Drugs (1) |
CMF-15520 | RASGRF1 | down-regulates | FOXD3 | represses | R-572 | 25 | 2 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-16665 | DNAJC11 | down-regulates | SIX6 | represses | R-3175 | 4 | 2 | Drugs (1) |
CMF-16828 | ADAMTS2 | up-regulates | ELF4 | activates | R-3010 | 20 | 3 | Drugs (9) |
CMF-17385 | TBC1D8 | down-regulates | SIX6 | represses | R-3175 | 4 | 1 | Drugs (1) |
CMF-18888 | INPP5J | down-regulates | ELF4 | activates | R-3010 | 20 | 5 | Drugs (9) |
CMF-19253 | NF1 | down-regulates | FOXD3 | represses | R-572 | 25 | 8 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-19326 | NF1 | down-regulates | SIX6 | represses | R-3175 | 4 | 4 | Drugs (1) |
CMF-19481 | NF1 | up-regulates | ELF4 | activates | R-3010 | 20 | 14 | Drugs (9) |
CMF-19656 | RPSAP58 | down-regulates | SIX6 | represses | R-3175 | 4 | 1 | Drugs (1) |
CMF-20128 | TDRD9 | down-regulates | SIX6 | represses | R-3175 | 4 | 3 | Drugs (1) |
CMF-21016 | KRTAP4-7 | down-regulates | FOXD3 | represses | R-572 | 25 | 8 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-21061 | KRTAP4-7 | up-regulates | ELF4 | activates | R-3010 | 20 | 8 | Drugs (9) |
CMF-21531 | KLHL34 | down-regulates | ELF4 | activates | R-3010 | 20 | 6 | Drugs (9) |
CMF-21693 | MUC17 | up-regulates | ELF4 | activates | R-3010 | 20 | 9 | Drugs (9) |
CMF-22158 | PDGFRA | down-regulates | ELF4 | activates | R-3010 | 20 | 1 | Drugs (9) |
CMF-22754 | IDH1 | down-regulates | ELF4 | activates | R-3010 | 20 | 11 | Drugs (9) |
CMF-24605 | THADA | down-regulates | ELF4 | activates | R-3010 | 20 | 4 | Drugs (9) |
CMF-25744 | CHN2 | down-regulates | SIX6 | represses | R-3175 | 4 | 1 | Drugs (1) |
CMF-27376 | FGD5 | down-regulates | ELF4 | activates | R-3010 | 20 | 2 | Drugs (9) |
CMF-27611 | ANKRD36 | down-regulates | SIX6 | represses | R-3175 | 4 | 2 | Drugs (1) |
CMF-29223 | AQP10 | down-regulates | ELF4 | activates | R-3010 | 20 | 6 | Drugs (9) |
CMF-29391 | PTCHD3 | down-regulates | ELF4 | activates | R-3010 | 20 | 4 | Drugs (9) |
CMF-30643 | SALL4 | down-regulates | ELF4 | activates | R-3010 | 20 | 4 | Drugs (9) |
CMF-33963 | MCM6 | down-regulates | hsa-mir-139 | represses | R-572 | 58 | 34 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-33968 | MCM6 | down-regulates | hsa-mir-139 | represses | R-3010 | 58 | 34 | Drugs (9) |
CMF-34010 | MCM6 | down-regulates | hsa-mir-129 | represses | R-572 | 155 | 76 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-34028 | MCM6 | down-regulates | hsa-mir-129 | represses | R-3010 | 155 | 76 | Drugs (9) |
CMF-34568 | TYK2 | up-regulates | hsa-mir-9 | represses | R-3010 | 25 | 5 | Drugs (9) |
CMF-34735 | ABCC5 | up-regulates | hsa-mir-139 | represses | R-572 | 58 | 26 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-34742 | ABCC5 | up-regulates | hsa-mir-139 | represses | R-3010 | 58 | 26 | Drugs (9) |
CMF-34819 | NUP210L | up-regulates | hsa-mir-9 | represses | R-572 | 25 | 20 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-34821 | NUP210L | up-regulates | hsa-mir-9 | represses | R-3010 | 25 | 20 | Drugs (9) |
CMF-35224 | ATRX | up-regulates | hsa-mir-139 | represses | R-572 | 58 | 58 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-35234 | ATRX | up-regulates | hsa-mir-139 | represses | R-3010 | 58 | 58 | Drugs (9) |
CMF-35323 | ATRX | up-regulates | hsa-mir-551b | represses | R-572 | 22 | 17 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-35327 | ATRX | up-regulates | hsa-mir-551b | represses | R-3010 | 22 | 17 | Drugs (9) |
CMF-35362 | ATRX | up-regulates | hsa-mir-98 | represses | R-3010 | 8 | 8 | Drugs (9) |
CMF-35376 | ATRX | up-regulates | hsa-mir-301 | represses | R-572 | 37 | 32 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-35385 | ATRX | up-regulates | hsa-mir-301 | represses | R-3010 | 37 | 32 | Drugs (9) |
CMF-35572 | ATRX | up-regulates | hsa-mir-9 | represses | R-572 | 25 | 25 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-35574 | ATRX | up-regulates | hsa-mir-9 | represses | R-3010 | 25 | 25 | Drugs (9) |
CMF-36125 | FAM47A | up-regulates | hsa-mir-301 | represses | R-572 | 37 | 1 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-36246 | TRIM6-TRIM34 | up-regulates | hsa-mir-9 | represses | R-572 | 25 | 2 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-36247 | TRIM6-TRIM34 | up-regulates | hsa-mir-9 | represses | R-3010 | 25 | 2 | Drugs (9) |
CMF-36310 | FOXR2 | up-regulates | hsa-mir-301 | represses | R-572 | 37 | 12 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-36315 | FOXR2 | up-regulates | hsa-mir-301 | represses | R-3010 | 37 | 12 | Drugs (9) |
CMF-36843 | SEMG1 | up-regulates | hsa-mir-9 | represses | R-572 | 25 | 5 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-36845 | SEMG1 | up-regulates | hsa-mir-9 | represses | R-3010 | 25 | 5 | Drugs (9) |
CMF-37003 | ATF7IP2 | down-regulates | hsa-mir-139 | represses | R-3010 | 58 | 1 | Drugs (9) |
CMF-37016 | ATF7IP2 | down-regulates | hsa-mir-129 | represses | R-3010 | 155 | 20 | Drugs (9) |
CMF-37452 | HTR3E | up-regulates | hsa-mir-129 | represses | R-572 | 155 | 71 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-37475 | HTR3E | up-regulates | hsa-mir-129 | represses | R-3010 | 155 | 71 | Drugs (9) |
CMF-37650 | NRXN1 | down-regulates | hsa-mir-551b | represses | R-572 | 22 | 3 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-37652 | NRXN1 | down-regulates | hsa-mir-551b | represses | R-3010 | 22 | 3 | Drugs (9) |
CMF-39110 | DNMBP | down-regulates | hsa-mir-139 | represses | R-572 | 58 | 15 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-39492 | NF1 | down-regulates | hsa-mir-551b | represses | R-572 | 22 | 18 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-39496 | NF1 | down-regulates | hsa-mir-551b | represses | R-3010 | 22 | 18 | Drugs (9) |
CMF-39506 | NF1 | down-regulates | hsa-mir-153 | represses | R-572 | 62 | 28 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-39516 | NF1 | down-regulates | hsa-mir-153 | represses | R-3010 | 62 | 28 | Drugs (9) |
CMF-39653 | NF1 | down-regulates | hsa-mir-9 | represses | R-572 | 25 | 10 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-39655 | NF1 | down-regulates | hsa-mir-9 | represses | R-3010 | 25 | 10 | Drugs (9) |
CMF-39746 | RPSAP58 | down-regulates | hsa-mir-301 | represses | R-572 | 37 | 12 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-39749 | RPSAP58 | down-regulates | hsa-mir-301 | represses | R-3010 | 37 | 12 | Drugs (9) |
CMF-40415 | PDGFRA | up-regulates | hsa-mir-9 | represses | R-572 | 25 | 7 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-40417 | PDGFRA | up-regulates | hsa-mir-9 | represses | R-3010 | 25 | 7 | Drugs (9) |
CMF-40468 | IDH1 | up-regulates | hsa-mir-139 | represses | R-572 | 58 | 58 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-40478 | IDH1 | up-regulates | hsa-mir-139 | represses | R-3010 | 58 | 58 | Drugs (9) |
CMF-40569 | IDH1 | up-regulates | hsa-mir-551b | represses | R-572 | 22 | 17 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-40573 | IDH1 | up-regulates | hsa-mir-551b | represses | R-3010 | 22 | 17 | Drugs (9) |
CMF-40603 | IDH1 | up-regulates | hsa-mir-153 | represses | R-572 | 62 | 62 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-40616 | IDH1 | up-regulates | hsa-mir-153 | represses | R-3010 | 62 | 62 | Drugs (9) |
CMF-40684 | IDH1 | up-regulates | hsa-mir-98 | represses | R-3010 | 8 | 8 | Drugs (9) |
CMF-40698 | IDH1 | up-regulates | hsa-mir-301 | represses | R-572 | 37 | 32 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-40707 | IDH1 | up-regulates | hsa-mir-301 | represses | R-3010 | 37 | 32 | Drugs (9) |
CMF-40862 | IDH1 | up-regulates | hsa-mir-9 | represses | R-572 | 25 | 25 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-40864 | IDH1 | up-regulates | hsa-mir-9 | represses | R-3010 | 25 | 25 | Drugs (9) |
CMF-41861 | IQSEC3 | up-regulates | hsa-mir-98 | represses | R-3010 | 8 | 7 | Drugs (9) |
CMF-41875 | IQSEC3 | up-regulates | hsa-mir-9 | represses | R-3010 | 25 | 17 | Drugs (9) |
CMF-42105 | CARD11 | up-regulates | hsa-mir-551b | represses | R-572 | 22 | 2 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-42106 | CARD11 | up-regulates | hsa-mir-551b | represses | R-3010 | 22 | 2 | Drugs (9) |
CMF-42107 | CARD11 | up-regulates | hsa-mir-98 | represses | R-3010 | 8 | 1 | Drugs (9) |
CMF-42280 | NBAS | down-regulates | hsa-mir-301 | represses | R-572 | 37 | 3 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-42281 | NBAS | down-regulates | hsa-mir-301 | represses | R-3010 | 37 | 3 | Drugs (9) |
CMF-42447 | ANKRD36 | down-regulates | hsa-mir-9 | represses | R-572 | 25 | 11 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-42449 | ANKRD36 | down-regulates | hsa-mir-9 | represses | R-3010 | 25 | 11 | Drugs (9) |
CMF-42478 | SLC22A9 | down-regulates | hsa-mir-153 | represses | R-572 | 62 | 1 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-42639 | MYO9B | up-regulates | hsa-mir-129 | represses | R-572 | 155 | 15 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, TOSEDOSTAT, BHQ-880, ABITUZUMAB |
CMF-42646 | MYO9B | up-regulates | hsa-mir-129 | represses | R-3010 | 155 | 15 | Drugs (9) |
CMF-42771 | AQP10 | up-regulates | hsa-mir-129 | represses | R-3010 | 155 | 41 | Drugs (9) |
CMF-42791 | AQP10 | up-regulates | hsa-mir-301 | represses | R-3010 | 37 | 10 | Drugs (9) |